High angiogenesis pathway score gliomas demonstrated a predilection for aggressive clinicopathological characteristics, such as higher grade, IDH wildtype genotype, 1p19q non-codeletion, MGMT promoter unmethylated status, and mesenchymal subtype. The gene discussed is MGMT; the disease is glioma.